Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
2022 | |||
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong Journal:Cost Effectiveness and Resource Allocation | 2020 | ||
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong Proceeding/Conference:Annals of Oncology | 2016 | ||
Overview of Stigma against Psychiatric Illnesses and Advancements of Anti-Stigma Activities in Six Asian Societies Journal:International Journal of Environmental Research and Public Health | 2020 |